Journal
JOURNAL OF SURGICAL ONCOLOGY
Volume 123, Issue 6, Pages 1395-1404Publisher
WILEY
DOI: 10.1002/jso.26415
Keywords
irreversible electroporation; locally advanced pancreatic cancer; total neoadjuvant therapy
Ask authors/readers for more resources
The annual incidence of pancreatic cancer is nearly 50,000 patients, with a 5-year overall survival rate of only 9%. Multidisciplinary therapy, including systemic chemotherapy, locoregional radiation, and surgery, is evolving to provide individualized and evidence-based treatment for patients with locally advanced disease.
The annual incidence of pancreatic cancer is nearly 50,000 patients. The 5-year overall survival is only 9%, and there remains a great need for better therapy. A subset of these patients presents with locally advanced disease. Multidisciplinary therapy has evolved to include some combination of systemic chemotherapy, locoregional radiation, and surgery in select patients with excellent biology. This review will address the thoughtful evidence-based and individualized approach to these patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available